Oncologists near Hackensack, NJ

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Peter C. Pan, MD is a board-certified assistant professor of neurology in the Division of Neuro-Oncology. He specializes in the treatment of brain tumors. He studied molecular biology and neurobiology at the University of California Berkeley, medicine at the State University of New York Downstate, and clinical neurology residency at the University of California Davis. He completed subspecialty training in Neuro-Oncology at NewYork-Presbyterian / Columbia University Irving Medical Center and NewYork-Presbyterian Weill Cornell Medical Center.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: I am proud to be one of the few physicians in the world who is nbsp;board certified in both neurology and neurological surgery and perhaps the only one also fellowship trained in neuro oncology My neuro oncology practice focuses on management of

Biography: Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors. Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.

Care Philosophy: Dr. Lassman's practice is restricted to Brain/CNS Tumors or metastases.

Biography: Aya Haggiagi, MD is an assistant professor of neurology at CUIMC, in the Division of Neuro-Oncology. Dr. Haggiagi is board certified in Neurology and Neuro-Oncology. She graduated with highest honors from the University of Al-Fateh School of Medicine in Tripoli, Libya. She subsequently completed a postdoctoral research fellowship in the Department of Pathology and Cell Biology at Columbia, under the mentorship of Dr. Michael Shelanski, where her research focused on biochemical and genetic changes in neurofibrillary tangle predominant dementia. Dr. Haggiagi then pursued her medicine internship training at Westchester Medical Center, followed by neurology residency at NewYork-Presbyterian/Columbia University Irving Medical Center. After residency, she completed a two-year fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center. Dr. Haggiagi was an attending physician and an investigator at Memorial Sloan Kettering Cancer Center prior to returning to NYP/CUIMC. She is the recipient of the Society for Neuro-Oncology 2017 Best Abstract Award. Her research interests include the development of clinical trials, precision medicine, and neurologic complications of immunotherapy.

Biography: Dr. Howard A. Fine was recently recruited to Weill Cornell to be the Founding Directorof the Brain Tumor Center in the Sandra and Edward Meyer Cancer Center and Associate Director for the Translational Research of the Weill Cornell Brain Tumor Center. He is also appointed as the Chief of the Division of Neuro-Oncology in the Department of Neurology.Dr. Fine received his medical degree at the Mount Sinai School of Medicine in New York City, completed an internship and residency in Internal Medicine at the University of Pennsylvania in Philadelphia, and a fellowship in Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School in Boston. Dr. Fine founded and Directed the Dana-Farber Cancer Institute Center for Neuro-Oncology at Harvard Medical School, and the Neuro-Oncology Branch, at the National Institutes of Health. Dr. Fine most recently served as Chief of the Division of Hematology and Oncology and as Deputy Director of the New York University Cancer CenterDr. Fine has a 26 year history of clinical and research work exclusively devoted to patients with brain tumors. He has run a basic and translational science laboratory continuously for those 26 years and has been involved in well over 100 brain tumor clinical trials. Dr. Fine has authored over 200 scholarly articles, reviews and book chapters in subjects all devoted to neuro-oncology/ brain tumors.Dr. Fine welcomes patients with brain tumors who wished to seek his consultation, care, and/or clinical trials.

Biography: Laura Donovan, MD is an Assistant Professor of Neurology at CUIMC in the Division of Neuro-Oncology. She completed her undergraduate work at Providence College and earned her medical degree from Emory University School of Medicine. Following an internship in internal medicine at Brown University/Rhode Island Hospital, she completed her neurology training at NYP/Columbia University. She served as Chief Resident of the Neurology Department at Columbia University from 2016-2017. She completed her fellowship training in Neuro-oncology at Columbia University Irving Medical Center and Weill Cornell Medical Center. Her research interests include improving care delivery and identifying interventions to improve quality of life in patients with primary and metastatic brain tumors.

Biography: Dr. Diaz is an assistant professor of Neurology at CUIMC, in the division of Neuro-Oncology. She is originally from Madrid, Spain, where she graduated medical school at Universidad Complutense de Madrid. She then moved to the US to continue her medical education, completing an internal medicine internship followed by neurology residency at University of Virginia. She then pursued a 3-year Neuro-oncology fellowship at Memorial Sloan Kettering Cancer Center, after which she joined NYP/CUIMC. Her research interests include tumor markers in cerebrospinal fluid (CSF) as well as clinical trials.

Biography: Dr. Jennifer H. Kuo is a board-certified surgeon-scientist nationally recognized for her expertise in the surgical treatment of thyroid, parathyroid, and adrenal diseases. Dr. Kuo is an accomplished, high-volume surgeon in minimally invasive surgical techniques, including trans-oral thyroidectomy and robotic adrenalectomy. She is one of the leading international experts in ultrasound-guided radiofrequency ablation of thyroid nodules and spearheaded the new Interventional Endocrinology program at Columbia. Dr. Kuo also serves as Program Director of the Endocrine Surgery Fellowship Program and the Endocrine Surgery Research program. Her research focuses on the use of predictive algorithms to improve and optimize care for endocrine patients, and is internationally recognized as a pioneer in the safe adoption of new technology in surgical care. She serves as Associate Editor for the Journal of Surgical Research, and serves on the Editorial Board for The World Journal of Surgery and VideoEndocrinology. Her commitment to excellent, innovative, and personalized care has been repeatedly recognized by Super Doctors and New York Magazine's Top Doctor Awards.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Salvatore Caruana is the Director of the Division of Head and Neck Surgery in the Department of Otolaryngology-Head and Neck Surgery at NewYork-Presbyterian Hospital Columbia University Medical Center. He is a widely respected head and neck surgeon in the forefront of the surgical treatment of tumors of the mouth pharynx, larynx and sinuses, parathyroid surgery, thyroid gland, and salivary glands. He is a pioneer in laser microsurgery for pharyngeal and laryngeal cancers. Dr. Caruana is an Associate Clinical Professor of Otolaryngology and Head and Neck Surgery at the Columbia University College of Physicians and Surgeons. Dr. Caruana graduated cum laude from the University of Buffalo and completed his Doctor of Medicine at Mount Sinai School of Medicine. His general surgery training at St. Vincent's Hospital and Medical Center was followed by a residency in Otolaryngology at New York Eye and Ear Infirmary. He then completed an NIH funded two-and-a-half-year fellowship in Head and Neck Surgical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Caruana's peer-reviewed research has included work centering upon the biological nature of several head and neck cancers and on the role of viruses in malignancies of the paranasal sinuses.

Biography: Dr. Konstantin Zakashansky, MD is an Oncology Specialist who practices in New York, NY. He is 54 years old and has been practicing for 25 years. Dr. Konstantin Zakashansky, MD is affiliated with Mount Sinai Brooklyn, Mount Sinai Queens and Mount Sinai Morningside.

Care Philosophy: Pancreatic cancer has been my area of clinical and research focus for the past 15 years. I participated in the process of recognition that outcomes of complex surgery such as that for pancreatic cancer are better in high volume centers when performed by experienced surgeons. In 2006, I conceived, funded and built a multidisciplinary unit with the mission of improving overall outcomes in pancreatic cancer care by integrating the care of multiple medical specialists.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person

Care Philosophy: My goals are to educate you and your family about your problem and fully explain the operative and non-operative options you have to treat your condition. I am always available to my patients and our team works tirelessly to keep access and the lines of communication open. Being presented with the diagnosis of a brain tumor can be stressful, and we work hard to ensure your time with us is useful, educational, and compassionate.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Care Philosophy: I am a medical oncologist who specializes in cancers of the lung and thymus. I work closely with our multidisciplinary team of expert thoracic surgeons, radiation oncologists, interventional radiologists, palliative care/pain management specialists, and nutritionists to provide comprehensive care for our patients. I view each patient and their disease as unique and work to manage their treatment accordingly, always keeping their goals in mind. In order to provide new hopes for the future of lung cancer treatment, our division is also involved in clinical research focusing on precsion medicine, immunotherapy, and novel therapeutics as well as laboratory research to better understand this disease.

Care Philosophy: As a board-certified general surgeon and surgical oncologist, I firmly believe in providing the best care to all of my patients. I believe in spending time with patients and families to ensure that they understand all of the options available to them. When surgery is indicated and the best course of action, I provide patients with the best surgical and medical care to ensure they can return to their lives and families.

Biography: Dr. S. Sunghyun Yoon is the Chief of the Division of Surgical Oncology and Vice-Chair of Surgical Oncology Research and Education in the Department of Surgery at Columbia University Irving Medical Center (CUIMC). Dr. Yoon is a national and international expert in the treatment of patients with sarcomas and other soft tissue tumors, gastric (stomach) and gastroesophageal cancers, gastrointestinal stromal tumors (GISTs), and melanoma. He also has over 18 years of experience in the treatment of other gastrointestinal and abdominal tumors, hepatobiliary tumors, neuroendocrine/adrenal tumors, lymphomas, and spleen tumors. He has been the principal investigator of several clinical trials examining novel treatment strategies and given numerous invited national and international lectures in relation to these cancers. Several of these trials have investigated the treatment of sarcomas, especially abdominal/retroperitoneal sarcomas, with advanced radiation techniques such as proton beam radiation and aggressive surgical resection to minimize local recurrence. Read More About These Treatments: https://columbiasurgery.org/conditions-and-treatments/retroperitoneal-sarcomas-and-pelvic-sarcomas Dr. Yoon was an early advocate for minimally invasive robotic surgery and has performed over 300 robotic procedures including robotic gastrectomies (stomach removal). He has one of the world's largest experiences in performing prophylactic total gastrectomies for patients with hereditary diffuse gastric cancer (HDGC syndrome) secondary to germline CDH1 mutation. He pioneered a technique for connection of the small bowel to the esophagus after total gastrectomy that is used by former surgical trainees and colleagues throughout the country due to its extremely low leakage rate. Dr. Yoon graduated from Harvard University and received his M.D. from the University of California at San Diego. He completed his residency in general surgery at Massachusetts General Hospital and his fellowship in surgical oncology at the Memorial Sloan-Kettering Cancer Center. He was an Associate Professor of Surgery at Massachusetts General Hospital and Harvard Medical School before joining the staff at Memorial Sloan-Kettering Cancer Center in 2012. Dr. Yoon was an Attending Surgeon in the Division of Gastric and Mixed Tumors at Memorial Sloan Kettering Cancer Center and a Professor of Surgery at Weill Cornell Medical College before joining CUIMC in 2021. Dr. Yoon's main research interests are in cancer stem cells and targeted biological agents in combination with chemotherapy and radiation therapy. His laboratory has been funded by the National Institutes of Health/National Cancer Institute for 18 years and strives to translate new research discoveries into the clinic. Dr. Yoon is also part of multi-institution research groups funded by Stand Up To Cancer and the DeGregorio Family Foundation to discover early diagnostics and new therapies for gastric cancer. His clinical and research efforts have led to over 150 original research articles, book chapters, and reviews. For a complete list of publications, please visit NCBI.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Biography: Dr. James Lee is an internationally recognized endocrine surgeon who specializes in the care of patients with thyroid, parathyroid, and adrenal disorders. Dr. Lee is the Chief of Endocrine Surgery and the Edwin K. and Anne C. Weisskopf Professor of Surgical Oncology at Columbia University and the Physician Director of the Endocrine Service Line at the NY Presbyterian Hospital. He serves as Co-Director of the multidisciplinary Columbia Thyroid Center, Parathyroid Center, and Adrenal Center. He has been rated as one of the Best Doctors in America and is one of the highest volume endocrine surgeons in the country. Dr. Lee received his medical degree from Columbia University's College of Physicians and Surgeons, completed his residency in General Surgery at Columbia and went on to a fellowship in Endocrine Surgery at the University of California, San Francisco. Dr. Lee is actively involved in the leadership of Endocrine Surgery at the national and international level. He serves on the Executive Council of the American Association of Endocrine Surgeons and Standing Faculty of the international Endocrine Surgery University. He co-created the inaugural Postgraduate Course in Endocrine Surgery at the American College of Surgeons and is a featured lecturer in the biannual Masters of Endocrine Surgery Course. He has authored over 100 articles and book chapters, including the AAES Parathyroidectomy Guidelines which sets the international standard for the care of patients with parathyroid disease. He is also the Co-Editor of Surgical Endocrinopathies and the Founding Figures which details state of the art care for patients with endocrine disorders as well as the rich history of discovery in the field. Dr. Lee has given over 100 invited lectures and visiting professorships at institutions around the world. He has travelled extensively to teach other endocrine surgeons advanced techniques such as minimally invasive thyroid and parathyroid surgery as well as laparoscopic retroperitoneal adrenalectomy. He has mentored dozens of clinical and research fellows over his career, many of whom are now leaders in their own institutions and abroad. Dr. Lee also serves as the Vice Chair of New Media in the Columbia University Department of Surgery and Chair of the ColumbiaDoctors Communications Committee. In this role, he oversees the digital strategy for multiple groups across the medical center with the mission of providing the highest quality education on health and wellness to the global audience.

Care Philosophy: I treat each person as a unique individual. I get to know that person and listen to the medical issue(s) that led him/her to see me. I spend time in conversation and examination to gather the information necessary for a diagnosis and treatment. I discuss the management options so that we can jointly select the appropriate treatment. Every question is welcomed. I enjoy learning about each person and sharing the benefit of my expertise. I hold sacred the trust placed in my care.

Care Philosophy: Everything that we do at our center, whether clinical care, research or education, is focused on helping patients. Here are some of the many reasons why patients tell us they come here - whether from the New York area, the surrounding region, or traveling from all over the country and other parts of the world in order to receive evaluation and treatment for lymphoma by our group. Patients seek treatment here because they are referred here by their physicians, who recognize our expertise and know that across the region and the country we are a "go to" place to seek the best lymphoma care. Our physicians are internationally recognized for clinical skill, research, and personal qualities. In fact, we care for a substantial number of individual physicians (or their family members) who are themselves dealing with lymphoma.